Bayer vs Clicks in a blood-thinning battle
Clicks and Bayer South Africa, the local scion of the multi-billion-dollar German pharmaceutical giant, were at war in the Patent Court last week.
Clicks and Bayer South Africa, the local scion of the multi-billion-dollar German pharmaceutical giant, were at war in the Patent Court last week.
Pharmaceutical giant Dis-Chem announced a healthy trading update for the first five-weeks of its financial year with revenue growth up 12.1%.
South Africa’s National Health Insurance system is set to be debated in Parliament soon, reports Reuters. The news agency describes the NHI as a flagship ANC policy.
Biznews founder Alec Hogg is joined by the Warwick Asset Management team. They’ll focus on how you as an investor can invest offshore, and why you should be diversifying.
Aspen plans to increase its Chinese presence as it ramps up distribution of its low-cost pharmaceuticals in the world’s most populous country.
Imperial will use foreign-credit facilities and cash to fund the acquisition of Palletways from UK private equity firm Phoenix Equity Partners.
Dr Jonathan Moch, Psychiatrist and self-professed professional student of the mind, brain, body and relationships delves into the common factor of successful businesses: central characters who add significant gravitas to their companies.
Balance is a prized quality in all our affairs. Including a nation’s trade. Being too heavily exposed one way or another exposes vulnerabilities that incentivise mischief.
The Rebosis Property Fund (JSE:REB) has pleased investors with 8% distribution growth. Its CEO talks about where money is to be made currently and in future.
After decades of resistance, I’ve now joined the “invest offshore” camp with the compilation of the Biznews portfolio. Here it is – four stocks and an ETF.